In pancreatic cancer, RIPK4 can promote cell migration and invasion via the phosphatidylethanolamine binding protein 1 (PEBP1) degradation-induce activation of the RAF1/MEK/ERK signaling pathway (Qi et al., 2018). The gene discussed is PEBP1; the disease is pancreatic neoplasm.